Clinical characteristics and predictive value of lower CD4+T cell level in patients with moderate and severe COVID-19: A multicenter retrospective study

Xuesong Wen(The Affiliated Yongchuan Hospital of Chongqing Medical University), Dongying Zhang(Huaian First People’s Hospital), Peng Lei(The Affiliated Yongchuan Hospital of Chongqing Medical University), Jun Xiao(Tongji Hospital), Xiao‐Wei Tan(The Affiliated Yongchuan Hospital of Chongqing Medical University), Yue Chen(Capital Medical University), Bin He(Soochow University), Lei Gao(Fujian Medical University), Jian Zhou(The Affiliated Yongchuan Hospital of Chongqing Medical University), Dan Jiang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Shu Qin(Shanxi Agricultural University), Xiaocheng Cheng(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Research Square
December 16, 2020
10.21203/rs.3.rs-46009/v3
Cited by 1

Related Papers

Prognostic value of NT-proBNP in patients with severe COVID-19
|Respiratory Research|2020|307
NR1D1 modulates synovial inflammation and bone destruction in rheumatoid arthritis
|Cell Death and Disease|2020|132
Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy
|Journal of Molecular Medicine|2018|106
Repetitive transcranial magnetic stimulation as an alternative therapy for dysphagia after stroke: a systematic review and meta-analysis
|Clinical Rehabilitation|2016|94
TNAP inhibition attenuates cardiac fibrosis induced by myocardial infarction through deactivating TGF-β1/Smads and activating P53 signaling pathways
|Cell Death and Disease|2020|93